As of 2025-01-23, the Relative Valuation of Charles River Laboratories International Inc (CRL) is 243.09 USD. This relative valuation is based on P/E multiples. With the latest stock price at 168.22 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is 44.5%.
The range of the Relative Valuation is 218.58 - 256.72 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.1x - 29.8x | 29.3x |
| Forward P/E multiples | 23.4x - 25.6x | 24.9x |
| Fair Price | 218.58 - 256.72 | 243.09 |
| Upside | 29.9% - 52.6% | 44.5% |
| Date | P/E |
| 2025-01-21 | 21.02 |
| 2025-01-17 | 20.24 |
| 2025-01-16 | 20.53 |
| 2025-01-15 | 21.53 |
| 2025-01-14 | 22.05 |
| 2025-01-13 | 23.54 |
| 2025-01-10 | 23.04 |
| 2025-01-08 | 23.26 |
| 2025-01-07 | 23.49 |
| 2025-01-06 | 23.47 |
| 2025-01-03 | 23.00 |
| 2025-01-02 | 22.61 |
| 2024-12-31 | 22.85 |
| 2024-12-30 | 22.71 |
| 2024-12-27 | 23.05 |
| 2024-12-26 | 23.11 |
| 2024-12-24 | 23.06 |
| 2024-12-23 | 22.95 |
| 2024-12-20 | 23.00 |
| 2024-12-19 | 22.55 |
| 2024-12-18 | 22.68 |
| 2024-12-17 | 23.44 |
| 2024-12-16 | 23.53 |
| 2024-12-13 | 23.58 |
| 2024-12-12 | 24.05 |
| 2024-12-11 | 23.96 |
| 2024-12-10 | 24.40 |
| 2024-12-09 | 24.98 |
| 2024-12-06 | 23.75 |
| 2024-12-05 | 23.71 |
| 2024-12-04 | 24.68 |
| 2024-12-03 | 24.67 |
| 2024-12-02 | 24.92 |
| 2024-11-29 | 24.64 |
| 2024-11-27 | 24.71 |
| 2024-11-26 | 24.48 |
| 2024-11-25 | 24.92 |
| 2024-11-22 | 24.24 |
| 2024-11-21 | 24.04 |
| 2024-11-20 | 23.26 |
| 2024-11-19 | 23.04 |
| 2024-11-18 | 23.21 |
| 2024-11-15 | 23.24 |
| 2024-11-14 | 24.38 |
| 2024-11-13 | 25.57 |
| 2024-11-12 | 26.73 |
| 2024-11-11 | 27.32 |
| 2024-11-08 | 26.67 |
| 2024-11-07 | 26.03 |
| 2024-11-06 | 26.52 |